Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate-to-severe atopic dermatitis in clinical practice: A retrospective cohort study

Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research